The clinical research industries growth is skyrocketing, the portion of the market outsourced to CROs is said to have grown from US$1 billion dollars in the early 1990’s to over US$17 billion in 2007. Analysts predict that by the year 2010 the industry could see numbers well into and over US$25 billion. Limdato www.limdato.com is seeing continued growth and expansion of its strategic relationships within the pharmaceutical industry. This continued growth for Limdato is due to companies looking not just for global expertise but specific therapeutic expertise also.